Generation Bio Co.’s filing revealed that its CHIEF OPERATING OFFICER Paone Antoinette unloaded Company’s shares for reported $14984.0 on Jan 26. In the deal valued at $5.56 per share,2,695 shares were sold. As a result of this transaction, Paone Antoinette now holds 0 shares worth roughly $ 0.0.
From Robots to Self-Driving Cars: 5 AI Stocks to Consider for Your Portfolio
The artificial intelligence (AI) revolution is already here and it's about to change everything we know about everything. With the global market for AI projected to grow from $137 billion in 2022 to over $1.81 trillion by 2030, there's never been a better time to invest in this burgeoning industry. That's why we've compiled a list of the Top 5 AI Stocks to Buy for 2023. These companies are at the forefront of the AI revolution, and have the potential to deliver huge returns to investors like you.
Get our free report, "Top 5 AI Stocks to Buy for 2023".
Sponsored
Then, Paone Antoinette sold 1,865 shares, generating $8,523 in total proceeds. Upon selling the shares at $4.57, the CHIEF OPERATING OFFICER now owns 0 shares.
Before that, Samayoa Phillip sold 1,865 shares. Generation Bio Co. shares valued at $9,530 were divested by the CHIEF STRATEGY OFFICER at a price of $5.11 per share. As a result of the transaction, Samayoa Phillip now holds 95,819 shares, worth roughly $0.38 million.
Canaccord Genuity initiated its Generation Bio Co. [GBIO] rating to a Buy in a research note published on Tuesday, November 08, 2022; the price target was $9. PT values the company’s stock at a premium of 56.0 to its Tuesday closing price. A number of analysts have revised their coverage, including William Blair’s analysts, who decreased its forecast for the stock in mid December from “an Outperform” to “a Mkt perform”. JMP Securities began covering GBIO with “Mkt outperform” recommendation on June 08, 2021. William Blair started covering the stock on February 24, 2021. It rated GBIO as “an Outperform”.
Price Performance Review of GBIO
On Tuesday, Generation Bio Co. [NASDAQ:GBIO] saw its stock fall -1.74% to $3.96. On the same session, the stock had its day’s lowest price of $3.93, but rose to a high of $4.19. Over the last five days, the stock has lost -10.61%. Generation Bio Co. shares have risen nearly 0.76% since the year began. Nevertheless, the stocks have fallen -21.74% over the past one year. While a 52-week high of $9.59 was reached on 02/06/23, a 52-week low of $3.55 was recorded on 01/03/23. SMA at 50 days reached $4.99, while 200 days put it at $5.67. A total of 1.06 million shares were traded, compared to the trading of 0.44 million shares in the previous session.
Levels Of Support And Resistance For GBIO Stock
The 24-hour chart illustrates a support level at 3.86, which if violated will result in even more drops to 3.77. On the upside, there is a resistance level at 4.12. A further resistance level may holdings at 4.29. The Relative Strength Index (RSI) on the 14-day chart is 32.41, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.88, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 94.70%. Stochastics %K at 5.87% indicates the stock is a buying.
How much short interest is there in Generation Bio Co.?
A steep rise in short interest was recorded in Generation Bio Co. stocks on Jan 12, 2023, dropping by -0.6 million shares to a total of 1.47 million shares. Yahoo Finance data shows the prior-month short interest on Dec 14, 2022 was 2.07 million shares. There was a decline of -40.82%, which implies that there is a negative sentiment for the stock. In spite of short shares comprising just 4.69% of the overall stock float, the days-to-cover ratio (short ratio) fell to 6.35.
Generation Bio Co. [GBIO] – Who Are The Largest Shareholders?
In filings from Fidelity Management & Research Co, it is revealed that the company now owns 8,832,176 shares, or roughly 14.86% of the outstanding GBIO shares. In other words, the investor’s shares have risen by 64,788 from its previous 13-F filing of 8767388.0. Additionally, T. Rowe Price Associates, Inc. decreased -1.82% of its stake after which the total value it holdings stand at $42,840,171. Over the last quarter, T. Rowe Price Investment Manageme purchased 95,138 shares of Generation Bio Co., while BlackRock Fund Advisors bought 236,110 shares. At present, PFM Health Sciences LP is holding 2,903,192 shares valued at $17.13 million. Invus Public Equities Advisors LL owned 2,814,191 shares of the company at the time of its most recent 13F filing, worth $16.6 million.
According to FactSet, Generation Bio Co.’s share price will average $13.00 in the next year, based on opinions of analysts polled by the firm. This is up nearly 185.36 percent from its previous closing price of $4.03. Analysts expect Generation Bio Co. stock to reach the higher price of $25.00, while the lowest price estimate is $7.00. However, 8 analysts have rated GBIO stock as an Overweight in their predictions for 2023. The most recent change occurred on February 18, 2021 when Needham began covering the stock and recommended ‘”a Buy”‘ rating along with a $50 price target.